1.      Abramson JS, Spika JS. Persistence of Neisseria meningitidis in the upper respiratory tract after intravenous antibiotic therapy for systemic meningococcal disease. J Infect Dis. 1985 Feb;151(2):370-1. doi: 10.1093/infdis/151.2.370.

2.      Alberio L. Protein C replacement in severe meningococcemia. Crit Care Med. 2001;29(8):1499-1503. doi:10.1097/00003246-200108000-00014.

3.      Algren JT, Lal S, Cutliff SA, et al. Predictors of outcome in acute meningococcal infection in children. Crit Care Med. 1993;21:447-452. doi:10.1097/00003246-199303000-00024.

4.      American Academy of Pediatrics. Meningococcal infections. In: Kimberlin DW, Banerjee R, Barnett ED, Lynfield R, Sawyer MH, eds. Red Book: 2024 Report of the Committee on Infectious Diseases. American Academy of Pediatrics; 2024: 585-599.

5.      Analysis of endemic meningococcal disease by serogroup and evaluation of chemoprophylaxis. J Infect Dis. 1976 Aug;134(2):201-4. doi: 10.1093/infdis/134.2.201.

6.      Angyo IA, Okpeh ES. Changing patterns of antibiotic sensitivity and resistance during an outbreak of meningococcal infection in Jos, Nigeria. J Trop Pediatr. 1998 Oct;44(5):263-5. doi: 10.1093/tropej/44.5.263.

7.      Arend SM, Lavrijsen APM, Kuijken I, et al. Prospective controlled study of the diagnostic value of skin biopsy in patients with presumed meningococcal disease. Eur J Clin Microbiol Infect Dis. 2006;25(10):643-649. doi:10.1007/s10096-006-0199-7.

8.      Barquet N, Domingo P, Caylà JA, et al; Barcelona Meningococcal Disease Surveillance Group. Prognostic factors in meningococcal disease: development of a bedside predictive model and scoring system. JAMA. 1997;278(6):491-496. doi:10.1001/jama.278.6.491.

9.      Benes J, Dzupova O, Kabelkova M, Krizova P, Gabrielova A. Infective endocarditis due to Neisseria meningitidis: two case reports. Clin Microbiol Infect. 2003 Oct;9(10):1062-4. doi: 10.1046/j.1469-0691.2003.00741.x.

10.  Berry I, Rubis AB, Howie RL, et al. Selection of antibiotics as prophylaxis for close contacts of patients with meningococcal disease in areas with ciprofloxacin resistance—United States, 2024. MMWR Morb Mortal Wkly Rep. 2024;73(4):99-104. doi:10.15585/mmwr.mm7304a2

11.  Bohr V, Rasmussen N, Hansen B, et al. 875 cases of bacterial meningitis: diagnostic procedures and the impact of preadmission antibiotic therapy. Part III of a three-part series. J Infect. 1983;7(3):193-202. doi:10.1016/S0163-4453(83)96980-3.

12.  Brandtzaeg P, Bryn K, Kierulf P, et al. Meningococcal endotoxin in lethal septic shock plasma studied by gas chromatography, mass-spectrometry, ultracentrifugation, and electron microscopy. J Clin Invest. 1992;89(3):816-823. doi:10.1172/JCI115660.

13.  Bryant PA, Li HY, Zaia A, et al. Prospective study of a real-time PCR that is highly sensitive, specific, and clinically useful for diagnosis of meningococcal disease in children. J Clin Microbiol. 2004;42(7):2919-2925. doi:10.1128/JCM.42.7.2919-2925.

14.  Carpenter RR, Petersdorf RG. The clinical spectrum of bacterial meningitis. Am J Med. 1962;33:262-275.

15.  Cartwright K, Reilly S, White D, et al. Early treatment with parenteral penicillin in meningococcal disease. BMJ. 1992;305(6846):143-147. doi:10.1136/bmj.305.6846.143

16.  Cavrini F, Liguori G, Andreoli A, et al. Multiple nucleotide substitutions in the Neisseria meningitidis serogroup C ctrA gene cause false-negative detection by real-time PCR. J Clin Microbiol. 2010;48(8):3016-3018. doi:10.1128/JCM.00103-10.

17.  Centers for Disease Control and Prevention. Guidance for the Evaluation and Public Health Management of Suspected Outbreaks of Meningococcal Disease. Version 2.0. September 2019. Accessed October 21, 2020. https://www.cdc.gov/meningococcal/downloads/meningococcal-outbreak-guidance.pdf

18.  Centers for Disease Control and Prevention. Public Health Strategies for Antibiotic-Resistant Neisseria meningitidis: Implementation Guidance for Health Departments. Accessed January 9, 2025. https://www.cdc.gov/meningococcal/php/antibiotic-resistant/index.html.

19.  Ceyhan M, Gürler N, Özsürekçi Y, et al. Meningitis caused by Neisseria meningitidis, Haemophilus influenzae type B and Streptococcus pneumoniae during 2005–2012 in Turkey: a multicenter prospective surveillance study. Hum Vaccin Immunother. 2014;10(11):2706-2712. doi:10.4161/hv.29678

20.  Ceyhan M, Özsürekçi Y, Gürler N, et al. Bacterial agents causing meningitis during 2013–2014 in Turkey: a multi-center hospital-based prospective surveillance study. Hum Vaccin Immunother. 2016;12(12):2940-2945. doi:10.1080/21645515.2016.1209278

21.  Ceyhan M, Yildirim I, Balmer P, et al. A prospective study of etiology of childhood acute bacterial meningitis, Turkey. Emerg Infect Dis. 2008;14(7):1089-1096. doi:10.3201/eid1407.070938

22.  Chaudhuri A, Martinez-Martin P, Kennedy PGE, et al. EFNS guideline on the management of community-acquired bacterial meningitis: report of an EFNS Task Force on acute bacterial meningitis in older children and adults. Eur J Neurol. 2008;15(7):649-659. doi:10.1111/j.1468-1331.2008.02193.

23.  Cohn AC, MacNeil JR, Clark TA, et al; Centers for Disease Control and Prevention (CDC). Prevention and control of meningococcal disease: recommendations of the Advisory Committee on Immunization Practices (ACIP). MMWR Recomm Rep 2013;62(RR-2):1-28.

24.  Contou D, Béduneau G, Rabault C, et al. Skin biopsy in adult patients with meningococcal purpura fulminans: a multicenter retrospective cohort study. Crit Care. 2023;27(1):166. doi:10.1186/s13054-023-04461-2.

25.  Corless CE, Guiver M, Borrow R, et al. Simultaneous detection of Neisseria meningitidis, Haemophilus influenzae, and Streptococcus pneumoniae in suspected cases of meningitis and septicemia using real-time PCR. J Clin Microbiol. 2001;39(4):1553-1558. doi:10.1128/JCM.39.4.1553-1558.

26.  Crosswell JM, Nicholson WR, Lennon DR. Rapid sterilisation of cerebrospinal fluid in meningococcal meningitis: Implications for treatment duration. J Paediatr Child Health. 2006;42(4):170-173. doi:10.1111/j.1440-1754.2006.00824.x.

27.  Darmstadt GL. Acute infectious purpura fulminans: pathogenesis and medical management. Pediatr Dermatol. 1998;15(3):169-183. doi:10.1046/j.1525-1470.1998.1998015169.x .

28.  Darton T, Guiver M, Naylor S, et al. Severity of meningococcal disease associated with genomic bacterial load. Clin Infect Dis. 2009;48(5):587-594. doi:10.1086/596707

29.  de Gans J, van de Beek D; European Dexamethasone in Adulthood Bacterial Meningitis Study Investigators. Dexamethasone in adults with bacterial meningitis. N Engl J Med. 2002;347(20):1549-1556. doi:10.1056/NEJMoa021334.

30.  Diggle MA, Clarke SC. Molecular methods for the detection and characterization of Neisseria meningitidis. Expert Rev Mol Diagn. 2006;6(1):79-87. doi:10.1586/14737159.6.1.79.

31.  Ducker TB, Simmons RL. The pathogenesis of meningitis. Systemic effect of meningococcal endotoxin within the cerebrospinal fluid. Arch Neurol. 1968;18(2):123-128. doi:10.1001/archneur.1968.00470320025002

32.  Durand ML, Calderwood SB, Weber DJ, et al. Acute bacterial meningitis in adults: a review of 493 episodes. N Engl J Med. 1993;328(1):21-28. doi:10.1056/NEJM199301073280104

33.  Faust SN, Levin M, Harrison OB, et al. Dysfunction of endothelial protein C activation in severe meningococcal sepsis. N Engl J Med. 2001;345(6):408-416. doi:10.1056/NEJM200108093450603.

34.  Feldman WE. Relation of concentrations of bacteria and bacterial antigen in cerebrospinal fluid to prognosis in patients with bacterial meningitis. N Engl J Med. 1977 Feb 24;296(8):433-5. doi: 10.1056/NEJM197702242960806.

35.  Fransen F, Heckenberg SG, Hamstra HJ, et al. Naturally occurring lipid A mutants in Neisseria meningitidis from patients with invasive meningococcal disease are associated with reduced coagulopathy. PLoS Pathog. 2009;5(4):e1000396. doi:10.1371/journal.ppat.1000396.

36.  Gardner P. Clinical practice. Prevention of meningococcal disease. N Engl J Med. 2006;355(14):1466-1473. doi:10.1056/NEJMcp063561.

37.  Hardman JM. Fatal meningococcal infections: the changing pathologic picture in the '60s. Mil Med. 1968 Dec;133(12):951-64.

38.  Hart CA, Thomson APJ. Meningococcal disease and its management in children. BMJ. 2006;333(7570):685-690. doi:10.1136/bmj.38968.683958.

39.  Hayden RT, Frenkel LD. More laboratory testing: greater cost but not necessarily better. Pediatr Infect Dis J. 2000 Apr;19(4):290-2. doi: 10.1097/00006454-200004000-00005.

40.  Heckenberg SGB, de Gans J, Brouwer MC, et al. Clinical features, outcome, and meningococcal genotype in 258 adults with meningococcal meningitis: a prospective cohort study. Medicine (Baltimore). 2008;87(4):185-192. doi:10.1097/MD.0b013e318180a6b4.

41.  Immunization Action Coalition. Meningococcal ACWY Vaccine Recommendations by Age and Risk Factor. Accessed October 26, 2020. https://www.immunize.org/catg.d/p2018.pdf

42.  Jaton K, Ninet B, Bille J, et al False-negative PCR result due to gene polymorphism: the example of Neisseria meningitidis. J Clin Microbiol. 2010 Dec;48(12):4590-1. doi: 10.1128/JCM.01766-10.

43.  Kahler CM, Stephens DS. Genetic basis for biosynthesis, structure, and function of meningococcal lipooligosaccharide (endotoxin). Crit Rev Microbiol. 1998;24(4):281-334. doi:10.1080/10408419891294216.

44.  Kanegaye JT, Soliemanzadeh P, Bradley JS. Lumbar puncture in pediatric bacterial meningitis: defining the time interval for recovery of cerebrospinal fluid pathogens after parenteral antibiotic pretreatment. Pediatrics. 2001;108(5):1169-1174.

45.  Kanter Dm, Learner N, Maurıello Da. Acute meningococcemia with vascular collapse: an analysis of 10 recently treated cases. Am J Med Sci. 1956 Dec;232(6):674-87. doi: 10.1097/00000441-195612000-00008.

46.  Kaplan SL, Schutze GE, Leake JA, et al. Multicenter surveillance of invasive meningococcal infections in children. Pediatrics. 2006;118(4):e979-e984. doi:10.1542/peds.2006-0429.

47.  Kerttula Y, Leinonen M, Koskela M, et al. The aetiology of pneumonia. Application of bacterial serology and basic laboratory methods. J Infect. 1987 Jan;14(1):21-30. doi: 10.1016/s0163-4453(87)90730-4.

48.  Koppes GM, Ellenbogen C, Gebhart RJ. Group Y meningococcal disease in United States Air Force recruits. Am J Med. 1977;62(5):661-6. doi: 10.1016/0002-9343(77)90867-1.

49.  Kroll JS, Stockwell PA, Aldred KJ, et al. Genetic drift and gene transfer at the capsulation locus in Neisseria meningitidis. J Bacteriol. 1988;170(6):2914-2923. doi:10.1128/jb.170.6.2914-2923.

50.  Lala HM, Alderslade RG, Walls K, et al. Meningococcal disease deaths and the frequency and cause of delays in antibiotic administration. N Z Med J. 2007;120(1263):U2696.

51.  Lécuyer H, Virion Z, Barnier JP, et al. An ADAM-10 dependent EPCR shedding links meningococcal interaction with endothelial cells to purpura fulminans. PLoS Pathog. 2018;14(4):e1006981. doi:10.1371/journal.ppat.1006981.

52.  Lentnek AL, Williams RR. Aztreonam in the treatment of gram-negative bacterial meningitis. Rev Infect Dis. 1991;13 Suppl 7:S586-S590. doi:10.1093/clinids/13.supplement_7.s586.

53.  Levin S, Painter MB. The treatment of acute meningococcal infection in adults. A reappraisal. Ann Intern Med. 1966;64(5):1049-56. doi: 10.7326/0003-4819-64-5-1049.

54.  Mbaeyi SA, Bozio CH, Duffy J, et al. Meningococcal vaccination: Recommendations of the Advisory Committee on Immunization Practices, United States, 2020. MMWR Recomm Rep. 2020;69(9):1-41. doi:10.15585/mmwr.rr6909a1

55.  McCracken GH Jr. Rapid identification of specific etiology in meningitis. J Pediatr. 1976 Apr;88(4 Pt 1):706-8. doi: 10.1016/s0022-3476(76)80067-4.

56.  McGill F, Heyderman RS, Michael BD, et al. The UK joint specialist societies guideline on the diagnosis and management of acute meningitis and meningococcal sepsis in immunocompetent adults.” J Infect. 2016;72(6):768-769. doi:10.1016/j.jinf.2016.04.001.

57.  McGraw TP, Bruckner DA. Evaluation of the Directigen and Phadebact agglutination tests. Am J Clin Pathol. 1984 Jul;82(1):97-9. doi: 10.1093/ajcp/82.1.97.

58.  McNamara LA, Potts C, Blain AE, et al. Detection of ciprofloxacin-resistant, β-lactamase–producing Neisseria meningitidis serogroup Y isolates — United States, 2019–2020. MMWR Morb Mortal Wkly Rep. 2020;69(24):735-739. doi:10.15585/mmwr.mm6924a2.

59.  Meini S, Bracalente I, Sbrana F, et al. Coagulative biomarkers differently predict clinical outcomes in invasive infections caused by Neisseria meningitidis and Streptococcus pneumoniae. Am J Med. 2025;138(3):504-512. doi:10.1016/j.amjmed.2024.10.020.

60.  Mendelman PM, Campos J, Chaffin DO, Serfass DA, Smith AL, Sáez-Nieto JA. Relative penicillin G resistance in Neisseria meningitidis and reduced affinity of penicillin-binding protein 3. Antimicrob Agents Chemother. 1988;32(5):706-709.doi:10.1128/AAC.32.5.706

61.  Merz AJ, So M. Attachment of piliated Neisseria gonorrhoeae and Neisseria meningitidis to epithelial cells elicits phase- and antigenic variation. Mol Microbiol. 1997;25(3):519-526. doi:10.1111/j.1365-2958.1997.406519.x

62.  Migeon CJ, Kenny FM, Hung W, et al. Study of adrenal function in children with meningitis. Pediatrics. 1967;40(2):163-183. doi:10.1016/0002-9343(68)90156-3.

63.  Morse JR, Oretsky MI, Hudson JA. Pericarditis as a complication of meningococcal meningitis. Ann Intern Med. 1971 Feb;74(2):212-7. doi: 10.7326/0003-4819-74-2-212.

64.  Muller PD, Donald PR, Burger PJ, et al. Detection of bacterial antigens in cerebrospinal fluid by a latex agglutination test in 'septic unknown' meningitis and serogroup B meningococcal meningitis. S Afr Med J. 1989 Sep 2;76(5):214-5.

65.  Neal KR, Nguyen-van-Tam JS, Slack RC, et al. Seven-week interval between acquisition of a meningococcus and the onset of invasive disease. A case report. Epidemiol Infect. 1999 Dec;123(3):507-9. doi: 10.1017/s0950268899003192.

66.  Newcombe J, Cartwright K, Palmer WH, et al. PCR of peripheral blood for diagnosis of meningococcal disease. J Clin Microbiol. 1996;34(7):1637-1640. doi:10.1128/JCM.34.7.1637-1640.

67.  Nieuwland R, Berckmans RJ, McGregor S, et al. Cellular origin and procoagulant properties of microparticles in meningococcal sepsis. Blood. 2000;95(3):930-935. doi:10.1182/blood.V95.3.930.

68.  Pathan N, Hemingway CA, Alizadeh AA, et al.Role of interleukin 6 in myocardial dysfunction of meningococcal septic shock. Lancet. 2004;363(9404):203-209. doi:10.1016/S0140-6736(03)15326-3.

69.  Persa OD, Jazmati N, Robinson N, et al. A pregnant woman with chronic meningococcaemia from Neisseria meningitidis with lpxL1-mutations. Lancet. 2014;384(9957):1900. doi:10.1016/S0140-6736(14)61645-7.

70.  Pierce HI, Cooper EB. Meningococcal pericarditis. Clinical features andd therapy in five patients. Arch Intern Med. 1972 Jun;129(6):918-22. doi: 10.1001/archinte.129.6.918.

71.  Potts CC, Rodriguez-Rivera LD, Retchless AC, et al. Antimicrobial susceptibility survey of invasive Neisseria meningitidis, United States 2012–2016. J Infect Dis. 2022;225(11):1871-1875. doi:10.1093/infdis/jiac095.

72.  Riordan FA. Improving promptness of antibiotic treatment in meningococcal disease. Emerg Med J. 2001;18(3):162-163. doi:10.1136/emj.18.3.162.

73.  Rosenstein NE, Perkins BA, Stephens DS, et al. Meningococcal disease. N Engl J Med. 2001;344(18):1378-1388. doi:10.1056/NEJM200105033441807

74.  Rubis A, Schillie S. Chapter 8: Meningococcal disease. In: Roush SW, Baldy LM, Mulroy J, eds. Manual for the Surveillance of Vaccine-Preventable Diseases. Centers for Disease Control and Prevention. Accessed January 9, 2025. https://www.cdc.gov/surv-manual/php/table-of-contents/chapter-8-meningococcal-disease.html

75.  Rudel T, Boxberger HJ, Meyer TF. Pilus biogenesis and epithelial cell adherence of Neisseria gonorrhoeae pilC double knock-out mutants. Mol Microbiol. 1995;17(6):1057-1071. doi:10.1111/j.1365-2958.1995.mmi_17061057.x

76.  Schaad UB. Arthritis in disease due to Neisseria meningitidis. Rev Infect Dis. 1980 Nov-Dec;2(6):880-8. doi: 10.1093/clinids/2.6.880.

77.  Schillie S, Loehr J, Chen WH, et al. New dosing interval and schedule for the Bexsero MenB-4C vaccine: Updated recommendations of the Advisory Committee on Immunization Practices — United States, October 2024. MMWR Morb Mortal Wkly Rep. 2024;73(46):1124-1129. doi:10.15585/mmwr.mm7346a3

78.  Schwentker FF, Gelman S, Long PH. Landmark article April 24, 1937. The treatment of meningococcic meningitis with sulfanilamide. Preliminary report. By Francis F. Schwentker, Sidney Gelman, and Perrin H. Long. JAMA. 1984 Feb 10;251(6):788-90. doi: 10.1001/jama.251.6.788.

79.  Seib KL, Scarselli M, Comanducci M, et al. Neisseria meningitidis factor H‐binding protein fHbp: a key virulence factor and vaccine antigen. Expert Rev Vaccines. 2015;14(6):841-859. doi:10.1586/14760584.2015.1016915.

80.  Sivalingam P, Tully AM. Acute meningococcal epiglottitis and septicaemia in a 65-y-old man. Scand J Infect Dis. 1998;30(2):196-8. doi: 10.1080/003655498750003654.

81.  Smith OP, White B, Vaughan D, et al. Use of protein-C concentrate, heparin, and haemodiafiltration in meningococcus-induced purpura fulminans. Lancet. 1997 Nov 29;350(9091):1590-3. doi: 10.1016/s0140-6736(97)06356-3.

82.  Sun YH, Bakshi S, Chalmers R, et al. Functional genomics of Neisseria meningitidis pathogenesis. Nat Med. 2000;6(11):1269-1273. doi:10.1038/81380

83.  T.C. Sağlık Bakanlığı, Halk Sağlığı Genel Müdürlüğü. Menenjit [Internet]. Accessed August 23, 2025. https://hsgm.saglik.gov.tr/tr/hastaliklar/menenjit.html.

84.  Thompson MJ, Ninis N, Perera R, et al. Clinical recognition of meningococcal disease in children and adolescents. Lancet. 2006;367(9508):397-403. doi:10.1016/S0140-6736(06)67932-4.

85.  Tobın JL. Complications of meningococcus infection in a series of sixty-three consecutive sporadic cases. Am J Med Sci. 1956 Mar;231(3):241-8. doi: 10.1097/00000441-195603000-00001.

86.  Tunkel AR, Hartman BJ, Kaplan SL, et al. Practice guidelines for the management of bacterial meningitis. Clin Infect Dis. 2004;39(9):1267-1284. doi:10.1086/425368.

87.  Tzeng Y-L, Thomas J, Stephens DS. Regulation of capsule in Neisseria meningitidis. Crit Rev Microbiol. 2016;42(5):759-772. doi:10.3109/1040841X.2015.1022507

88.  Uadiale K, Sambo B, Olayinka AT, et al. Evaluation of Pastorex meningitis kit performance for the rapid diagnosis of meningococcal disease. Afr J Clin Exp Microbiol. 2006;7(1):36-40.

89.  Virji M, Makepeace K, Ferguson DJ, et al. Meningococcal Opa and Opc proteins: their role in colonization and invasion of human epithelial and endothelial cells. Mol Microbiol. 1993;10(3):499-510. doi:10.1111/j.1365-2958.1993.tb00922.x.

90.  Virji M, Makepeace K, Peak I, et al. Functional implications of the expression of PilC proteins in meningococci. Mol Microbiol. 1995;16(6):1087-1097. doi:10.1111/j.1365-2958.1995.tb02334.x

91.  Vries F, Ende A, Putten JP, et al. Invasion of primary nasopharyngeal epithelial cells by Neisseria meningitidis is controlled by phase variation of multiple surface antigens. Infect Immun. 1996;64(8):2998-3006. doi:10.1128/iai.64.8.2998-3006.

92.  Wang VJ, Malley R, Fleisher GR, et al. Antibiotic treatment of children with unsuspected meningococcal disease. Arch Pediatr Adolesc Med. 2000 Jun;154(6):556-60. doi: 10.1001/archpedi.154.6.556

93.  White B, Livingstone W, Murphy C, et al. An open-label study of the role of adjuvant hemostatic support with protein C replacement therapy in purpura fulminans-associated meningococcemia. Blood. 2000 Dec 1;96(12):3719-24.

94.  Willerton L, Lucidarme J, Walker A, et al. Antibiotic resistance among invasive Neisseria meningitidis isolates in England, Wales and Northern Ireland (2010/11 to 2018/19). PLoS One. 2021;16(11):e0260677. doi:10.1371/journal.pone.0260677.

95.  Wolf RE, Birbara CA. Meningococcal infections at an army training center. Am J Med. 1968;44(2):243-255. doi:10.1016/0002-9343(68)90156-3.

96.  Wong VK, Hitchcock W, Mason WH. Meningococcal infections in children: a review of 100 cases. Pediatr Infect Dis J. 1989;8(4):224-227.

97.  Yazdankhah SP, Caugant DA. Neisseria meningitidis: an overview of the carriage state. J Med Microbiol. 2004;53(pt 9):821-832. doi:10.1099/jmm.0.45529-0